Lexaria Bioscience Corp (LEXX)
3.11
+0.13
(+4.36%)
USD |
NASDAQ |
May 03, 16:00
3.11
0.00 (0.00%)
After-Hours: 16:37
Lexaria Bioscience Cash from Operations (TTM): -5.209M for Feb. 29, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | -5.209M |
| November 30, 2023 | -5.818M |
| August 31, 2023 | -5.881M |
| May 31, 2023 | -5.436M |
| February 28, 2023 | -4.909M |
| November 30, 2022 | -4.958M |
| August 31, 2022 | -4.879M |
| May 31, 2022 | -4.815M |
| February 28, 2022 | -4.712M |
| November 30, 2021 | -4.346M |
| August 31, 2021 | -3.990M |
| May 31, 2021 | -3.517M |
| February 28, 2021 | -3.031M |
| November 30, 2020 | -2.873M |
| August 31, 2020 | -2.619M |
| May 31, 2020 | -2.716M |
| February 29, 2020 | -3.147M |
| November 30, 2019 | -2.996M |
| August 31, 2019 | -3.006M |
| May 31, 2019 | -3.106M |
| February 28, 2019 | -2.564M |
| November 30, 2018 | -2.562M |
| August 31, 2018 | -2.518M |
| May 31, 2018 | -2.034M |
| February 28, 2018 | -2.078M |
| Date | Value |
|---|---|
| November 30, 2017 | -1.965M |
| August 31, 2017 | -1.546M |
| May 31, 2017 | -1.453M |
| February 28, 2017 | -0.9582M |
| November 30, 2016 | -0.5529M |
| August 31, 2016 | -0.6609M |
| May 31, 2016 | -0.981M |
| February 29, 2016 | -1.259M |
| November 30, 2015 | -1.537M |
| August 31, 2015 | -1.501M |
| May 31, 2015 | -1.143M |
| February 28, 2015 | -0.8539M |
| November 30, 2014 | -0.5849M |
| July 31, 2014 | -0.3374M |
| April 30, 2014 | -0.0543M |
| January 31, 2014 | 0.1666M |
| October 31, 2013 | 0.321M |
| July 31, 2013 | 0.4503M |
| April 30, 2013 | 0.4378M |
| January 31, 2013 | 0.244M |
| October 31, 2012 | 0.1359M |
| July 31, 2012 | 0.2252M |
| April 30, 2012 | 0.1493M |
| January 31, 2012 | 0.1354M |
| October 31, 2011 | 0.1098M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-5.881M
Minimum
Aug 2023
-2.619M
Maximum
Aug 2020
-4.098M
Average
-4.168M
Median
Cash from Operations (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | -33.46M |
| Sunshine Biopharma Inc | -8.775M |
| Acasti Pharma Inc | -13.57M |
| Edesa Biotech Inc | -6.252M |
| Xenon Pharmaceuticals Inc | -145.33M |